Reporting of Incidence and Outcome of Bone Metastases in Clinical Trials Enrolling Patients with Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma—A Systematic Review

SIMPLE SUMMARY: Around 30–60% of the patients with lung cancer develop bone metastases, which are associated with decreased survival, bone pain, and skeletal-related events such as need for radiation. Patients with an epidermal growth factor mutation (EGFR), a subgroup of the patients with lung canc...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancers (Basel)
Huvudupphovsmän: Brouns, Anita, Dursun, Safiye, Bootsma, Gerben, Dingemans, Anne-Marie C., Hendriks, Lizza
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2021
Ämnen:
Systematic Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8267949/
https://ncbi.nlm.nih.gov/pubmed/34201833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133144
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk